David Toung
Stock Analyst at Argus Research
(4.44)
# 209
Out of 4,814 analysts
118
Total ratings
65.22%
Success rate
10.93%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $15.79 | - | 2 | Mar 31, 2025 | |
| ELV Elevance Health | Reiterates: Hold | $405 | $435.04 | -6.81% | 1 | Jan 29, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $171.71 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $134.36 | -6.97% | 9 | Sep 11, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $570 → $600 | $585.04 | +2.56% | 7 | Jul 17, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $104.25 | - | 5 | Jun 28, 2024 | |
| AMGN Amgen | Maintains: Buy | $300 → $340 | $282.64 | +20.29% | 10 | Jun 27, 2024 | |
| MCK McKesson | Maintains: Buy | $570 → $670 | $695.00 | -3.60% | 6 | Jun 24, 2024 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Buy | $150 | $96.94 | +54.73% | 7 | May 21, 2024 | |
| LLY Eli Lilly and Company | Maintains: Buy | $770 → $840 | $734.59 | +14.35% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $95 | $56.55 | +67.99% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $61.48 | +78.92% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $220.57 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $22.04 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $285.61 | - | 8 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $540 → $550 | $436.79 | +25.92% | 6 | Nov 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $346.67 | -10.58% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $331.00 | -6.34% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $481.34 | -33.52% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $129.70 | +4.09% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $104.88 | -28.49% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $49.36 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $76.46 | +43.87% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $82.70 | +99.52% | 6 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.90 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $50.05 | +144.76% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $67.05 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $109.58 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $153.91 | +0.71% | 4 | Mar 27, 2020 |
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $15.79
Upside: -
Elevance Health
Jan 29, 2025
Reiterates: Hold
Price Target: $405
Current: $435.04
Upside: -6.81%
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $171.71
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $134.36
Upside: -6.97%
UnitedHealth Group
Jul 17, 2024
Maintains: Buy
Price Target: $570 → $600
Current: $585.04
Upside: +2.56%
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $104.25
Upside: -
Amgen
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $282.64
Upside: +20.29%
McKesson
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $695.00
Upside: -3.60%
Zimmer Biomet Holdings
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $96.94
Upside: +54.73%
Eli Lilly and Company
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $734.59
Upside: +14.35%
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $56.55
Upside: +67.99%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $61.48
Upside: +78.92%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $220.57
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $22.04
Upside: -
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $285.61
Upside: -
Nov 6, 2023
Maintains: Buy
Price Target: $540 → $550
Current: $436.79
Upside: +25.92%
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $346.67
Upside: -10.58%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $331.00
Upside: -6.34%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $481.34
Upside: -33.52%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $129.70
Upside: +4.09%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $104.88
Upside: -28.49%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $49.36
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $76.46
Upside: +43.87%
Aug 27, 2021
Maintains: Buy
Price Target: $150 → $165
Current: $82.70
Upside: +99.52%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $6.90
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $50.05
Upside: +144.76%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $67.05
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $109.58
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $153.91
Upside: +0.71%